Influence of potassium channel modulators on cognitive processes in mice

British Journal of Pharmacology

Volumn 123, Issue 6, 1998, Pages 1079-1084

  Ghelardini, Carla ^a   Galeotti, Nicoletta ^a   Bartolini, Alessandro ^a  

^a Dept Preclin and Clin Pharmacol ^*  (Italy)

Author keywords

Apamin; Charybdotoxin; Cromakalim; Learning and memory; Minoxidil; Pinacidil; Potassium channel antagonists; Potassium channel openers; Sulphonylureas; Tetraethylammonium

Indexed keywords

APAMIN; CHARYBDOTOXIN; CROMAKALIM; GLIBENCLAMIDE; GLIQUIDONE; MINOXIDIL; PINACIDIL; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM CHANNEL STIMULATING AGENT; TETRYLAMMONIUM;

ANIMAL EXPERIMENT; ARTICLE; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MEMORY; MOUSE; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; SUBCUTANEOUS DRUG ADMINISTRATION;

AMNESIA; ANIMALS; APAMIN; AVOIDANCE LEARNING; CHARYBDOTOXIN; CROMAKALIM; GLYBURIDE; GUANIDINES; INJECTIONS, INTRAVENTRICULAR; MALE; MICE; MINOXIDIL; PINACIDIL; POTASSIUM CHANNELS; SULFONYLUREA COMPOUNDS; TETRAETHYLAMMONIUM;

EID: 0031887635     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701709     Document Type: Article

References (25)

1. ALKON, D.L., LEDERHENDLER, I. & SHOUKIMAS, J.L. (1982). Primary changes of membrane currents during retention of associative learning. Science, 215, 693-695.
2. ARONSON, J.K. (1992). Potassium channels in nervous tissue. Biochem. Pharmacol., 43, 11-14.
3. + channels in olfactory neuroblasts from Alzheimer's and normal donors. Soc. Neurosci. Abstr., 20, 1673.
4. + channels. Clin. Exp. Pharmacol. Physiol., 22, 944-951.
5. COOK, N.S. (1988). The pharmacology of potassium channels and their therapeutic potential. Trends Pharmacol. Sci., 9, 21-28.
6. COOK, N.S. & QUAST, U. (1990). Potassium channel pharmacology. In Potassium Channels: Structure, Classification, Function and Therapeutic Potential. ed. Cook, N.S. 181-255. Chichester: Ellis Horwood Limited.
7. + channel, on habituation and passive avoidance responses in rats. Neurosci. Lett., 227, 57-60.
8. DESCHAUX, O., BIZOT, J.C. & GOYFFON, M. (1997). Apamin improves learning in an object recognition task in rats. Neurosci. Lett., 222, 159-162.
9. EDWARDS, G. & WESTON, A.H. (1993). The pharmacology of ATP-sensitive potassium channels. Annu. Rev. Pharmacol. Toxicol., 33, 597-637.
10. + channels. Science, 264, 276-279.
11. ETCHEBERRIGARAY, R., ITO, E., OKA, K., TOFEL-GREHL, B., GIBSON, G.E. & ALKON, D. (1993). Potassium channel dysfunction in fibroblasts identifies patients with Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 90, 8209-8213.
12. FUDEBERG, H.H., WHITTEN, H.D., ARNAULD, P., KHANSARI, N., TSANG, K.Y. & HAMES, C.G. (1984). Immune diagnosis of a subset of Alzheimer's disease with preliminary implications for immunotherapy. Biomed. Pharmacother., 38, 290-297.
13. GUALTIERI, F., BOTTALICO, C., CALANDRELLA, A., DEI, S., GIOVANNONI, P., MEALLI, S., ROMANELLI, M.N., SCAPECCHI, S., TEODORI, E., GALEOTTI, N., GHELARDINI, C., BARTOLINI, A. & GIOTTI, A. (1994). Presynaptic cholinergic modulators as potent nootropic and analgesic drugs. II. 2-phenoxy, 2-phenylthio and 2-phenylamino alkanoic acid esters. J. Med. Chem., 37, 1712-1719.
14. HALEY, T.J. & MCCORMICK, W.G. (1957). Pharmacological effects produced by intracerebral injection of drugs in conscious mouse. Br. J. Pharmacol. Chemother., 12, 12-15.
15. + channels in the central nervous system. In Potassium Channels: Structure, Classification, Function and Therapeutic Potential. ed. Cook, N.S. 348-381. Chichester: Ellis Horwood Limited.
16. JARVIK, M.E. & KOPP, R. (1967). An improved one-trial passive avoidance learning situation. Psychol. Rep., 21, 221-224.
17. LONGMAN, S.D. & HAMILTON, T.C. (1992). Potassium channel activator drugs: mechanism of action, pharmacological properties, and therapeutic potential. Med. Res. Rev., 12, 73-148.
18. MEIRI, N., GHELARDINI, C., TESCO, G., GALEOTTI, N., DAHL, D., TOMSIC, D., CAVALLARO, S., QUATTRONE, A., CAPACCIOLI, S., BARTOLINI, A. & ALKON, D.L. (1997). Reversible antisense inhibition of Shaker-like Kv1.1 potassium channel expression impairs associative memory in mouse and rat. Proc. Natl. Acad. Sci. U.S.A., 94, 4430-4434.
19. MENEILLY, G.S., CHEUNG, E., TESSIER, D., YAKURA, C. & TUOKKO, H. (1993). The effect of improved glycemic control on cognitive functions in the elderly patients with diabetes. J. Gerontol., 48, 117-121.
20. + channels from mammalian skeletal muscle. Nature, 313, 316-318.
21. ROBERTS, E. (1986). Guides through the labyrinth of AD: dehydroepiandrosterone, potassium channels and C4 component of complement. In Treatment Development Strategies for Alzheimer's Disease. ed. Crook, T., Bartus, R., Ferris, S. & Gershon, S. pp. 173-219. Madison: Mark Powley Associates, Inc.
22. SANCHEZ-ANDRES & ALKON, D.L. (1991). Voltage-clamp analysis of the effects of classical conditioning on the hippocampus. J. Neurophysiol., 65, 796-807.
23. STRONG, P.N. (1990). Potassium channel toxins. Pharmacol. Ther., 46, 137-162.
24. STÜHMER, W., RUPPERSBERG, J.P., SCHRÖTER, K.H., SAKMANN, B., STOCKER, M., GIESE, K.P., PERSCHKE, A., BAUMANN, A. & PONGS, O. (1989). Molecular basis of functional diversity of voltage-gated potassium channels in mammalian brain. EMBO J., 8, 3235-3244.
25. VAUGHT, J., PELLEY, K., COSTA, L.G., SETHER, P. & ENNA, S.J. (1985). A comparison of the antinociceptive responses to GABA-receptor agonists THIP and baclofen. Neuropharmacology, 24, 211-216.